This is particularly relevant for: Short-acting agents (exenatide immediate-release, lixisenatide) May require timing separation from oral medications, particularly those requiring rapid absorption Weekly agents (semaglutide, dulaglutide, exenatide extended-release) Generally have minimal impact on oral contraceptive effectiveness Warfarin/coumarin anticoagulants More frequent INR monitoring may be advised when starting GLP-1 therapy Oral semaglutide (Rybelsus) has specific administration requirements (taking on an empty stomach with a small amount of water) to ensure proper absorption
Dietary Glycine Is Rate-Limiting for Glutathione Synthesis and May Have Broad Potential for Health Protection
Prior authorization may be required
Halminen J, Sattar N, Rawshani A et al (2022) Range of risk factor levels, risk control, and temporal trends for nephropathy and end-stage kidney disease in patients with type 1 and type 2 diabetes
Yet despite the abundance of choices, many users find themselves stuck with disappointing or short-lived results